In individuals in whom this adaptive response is preserved (i.e., those with the highest LBP levels), the obese phenotype might not be accompanied by metabolic consequences of chronic inflammation, lipotoxicity, and insulin resistance, and they are less prone to NAFLD and T2D onset. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.